Literature DB >> 26239638

Editorial: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics.

Zhong Wang, Dayue Darrel Duan1, Yong-Yan Wang.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26239638      PMCID： PMC4570267          DOI： 10.2174/157016111304150722171221

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN： 1570-1611            Impact factor:   2.719


× No keyword cloud information.
  24 in total

Review 1.  Cellular Membrane Microparticles: Potential Targets of Combinational Therapy for Vascular Disease.

Authors:  Xiang Xiao; Xiaotang Ma; Langni Liu; Jinju Wang; Kexia Bi; Yingxia Liu; Ran Fan; Bin Zhao; Yanfang Chen; Ji C Bihl
Journal:  Curr Vasc Pharmacol       Date:  2015       Impact factor: 2.719

Review 2.  Fangjiomics: in search of effective and safe combination therapies.

Authors:  Zhong Wang; Jun Liu; Yiyu Cheng; Yongyan Wang
Journal:  J Clin Pharmacol       Date:  2011-01-05       Impact factor: 3.126

Review 3.  Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.

Authors:  Mukul Sharma; Mohammed T Ansari; Ahmed M Abou-Setta; Karla Soares-Weiser; Teik Chye Ooi; Margaret Sears; Fatemeh Yazdi; Alexander Tsertsvadze; David Moher
Journal:  Ann Intern Med       Date:  2009-11-03       Impact factor: 25.391

Review 4.  Adoption in China of Clinical Practice Guidelines for hypertension using Traditional Chinese Medical approaches: a literature review based on clinical studies.

Authors:  Nannan Shi; Xuejie Han; Wenya Yu; Liying Wang; Aiping Lu
Journal:  J Altern Complement Med       Date:  2012-09-06       Impact factor: 2.579

5.  A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.

Authors:  K Melissa Hallow; Arthur Lo; Jeni Beh; Manoj Rodrigo; Sergey Ermakov; Stuart Friedman; Hector de Leon; Anamika Sarkar; Yuan Xiong; Ramesh Sarangapani; Henning Schmidt; Randy Webb; Anna Georgieva Kondic
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-05       Impact factor: 3.619

6.  Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine.

Authors:  Zhu-ye Gao; Hao Xu; Da-zhuo Shi; Chuan Wen; Bao-yan Liu
Journal:  J Ethnopharmacol       Date:  2011-09-08       Impact factor: 4.360

Review 7.  Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.

Authors:  Santiago Palacio; Robert G Hart; Lesly A Pearce; Oscar R Benavente
Journal:  Stroke       Date:  2012-08       Impact factor: 7.914

8.  Systems biology analysis unravels the complementary action of combined rosuvastatin and ezetimibe therapy.

Authors:  Lars Verschuren; Marijana Radonjic; Peter Y Wielinga; Thomas Kelder; Teake Kooistra; Ben van Ommen; Robert Kleemann
Journal:  Pharmacogenet Genomics       Date:  2012-12       Impact factor: 2.089

Review 9.  Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science.

Authors:  Xingjiang Xiong; Xiaochen Yang; Yongmei Liu; Yun Zhang; Pengqian Wang; Jie Wang
Journal:  Hypertens Res       Date:  2013-04-04       Impact factor: 3.872

10.  Combination therapy with atorvastatin and amlodipine suppresses angiotensin II-induced aortic aneurysm formation.

Authors:  Kikuyo Takahashi; Yasuharu Matsumoto; Zhulanqiqige Do e; Masanori Kanazawa; Kimio Satoh; Takuya Shimizu; Akira Sato; Yoshihiro Fukumoto; Hiroaki Shimokawa
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240
View more
  5 in total

1.  Duhuo Jisheng Decoction inhibits SDF-1-induced inflammation and matrix degradation in human degenerative nucleus pulposus cells in vitro through the CXCR4/NF-κB pathway.

Authors:  Zong-Chao Liu; Zhen-Long Wang; Chen-Yi Huang; Zhi-Jiang Fu; Yong Liu; Zhang-Chao Wei; Shi-Gui Liu; Chuan Ma; Jie-Liang Shen; Dayue Darrel Duan
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

2.  Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Bo-li Zhang; Yong-yan Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06       Impact factor: 6.150

3.  Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.

Authors:  Yan-Hong Luo; Min Zhu; Dong-Gang Wang; Yu-Sheng Yang; Tao Tan; Hua Zhu; Jian-Feng He
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

4.  Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice.

Authors:  Peng-Qian Wang; Qiong Liu; Wen-Juan Xu; Ya-Nan Yu; Ying-Ying Zhang; Bing Li; Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-01-18       Impact factor: 6.150

5.  IMCC: A Novel Quantitative Approach Revealing Variation of Global Modular Map and Local Inter-Module Coordination Among Differential Drug's Targeted Cerebral Ischemic Networks.

Authors:  Pengqian Wang; Yanan Yu; Jun Liu; Bing Li; Yingying Zhang; Dongfeng Li; Wenjuan Xu; Qiong Liu; Zhong Wang
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.